Development of cisplatin-loaded hydrogels for trans-portal vein chemoembolization in an orthotopic liver cancer mouse model

References

• Armstrong DK, Bundy B, Wenzel L, et al. (2006). Gynecologic oncology G. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34–43.
   PubMed Web of Science ®Google Scholar
• Balmanno K, Cook SJ. (2009). Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16:368–77.
   PubMed Web of Science ®Google Scholar
• Burmania JA, Stevens KR, Kao WJ. (2003). Cell interaction with protein-loaded interpenetrating networks containing modified gelatin and poly(ethylene glycol) diacrylate. Biomaterials 24:3921–30.
   PubMed Web of Science ®Google Scholar
• Chan BQY, Cheng H, Liow SS, et al. (2018). Poly(carbonate urethane)-based thermogels with enhanced drug release efficacy for chemotherapeutic applications. Polymers (Basel) 10:89.
   PubMed Web of Science ®Google Scholar
• Chen YP, Zhang JL, Zou Y, Wu YL. (2019). Recent advances on polymeric beads or hydrogels as embolization agents for improved transcatheter arterial chemoembolization (TACE). Front Chem 7:408.
   PubMed Web of Science ®Google Scholar
• De Francesco EM, Sims AH, Maggiolini M, et al. (2017). GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment. Breast Cancer Res 19:129.
   PubMed Web of Science ®Google Scholar
• Ferrara N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611.
   PubMed Web of Science ®Google Scholar
• Fu Y, Kao WJ. (2010). Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 7:429–44.
   PubMed Web of Science ®Google Scholar
• Fu Y, Xu K, Zheng X, et al. (2012). 3D cell entrapment in crosslinked thiolated gelatin-poly(ethylene glycol) diacrylate hydrogels. Biomaterials 33:48–58.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Hashemi M, Ande SR, et al. (2009). Apoptosis and cancer: mutations within caspase genes. J Med Genet 46:497–510.
   PubMed Web of Science ®Google Scholar
• Golfieri R, Cappelli A, Cucchetti A, et al. (2011). L. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology 53:1580–9.
   PubMed Web of Science ®Google Scholar
• Guerra AD, Rose WE, Hematti P, Kao WJ. (2017). Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels. Acta Biomater 51:184–96.
   PubMed Web of Science ®Google Scholar
• Guerra AD, Yeung OWH, Qi X, et al. (2017). The anti-tumor effects of M1 macrophage-loaded poly (ethylene glycol) and gelatin-based hydrogels on hepatocellular carcinoma. Theranostics 7:3732–44.
   PubMed Web of Science ®Google Scholar
• Guo JH, Zhu X, Li XT, Yang RJ. (2012). Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Chin J Cancer Res 24:36–43.
   PubMed Web of Science ®Google Scholar
• Hoare TR, Kohane DS. (2008). Hydrogels in drug delivery: progress and challenges. Polymer 49:1993–2007.
   Web of Science ®Google Scholar
• Idee JM, Guiu B. (2013). Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Crit Rev Oncol Hematol 88:530–49.
   PubMed Web of Science ®Google Scholar
• Kamat AM, Hahn NM, Efstathiou JA, et al. (2016). Bladder cancer. Lancet 388:2796–810.
   PubMed Web of Science ®Google Scholar
• Lencioni R, de Baere T, Burrel M, et al. (2012). Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol 35:980–5.
   PubMed Web of Science ®Google Scholar
• Lewis AL, Dreher MR. (2012). Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy. J Control Release 161:338–50.
   PubMed Web of Science ®Google Scholar
• Li CX, Ng KT, Shao Y, et al. (2014). The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response. Ann Surg 260:317–28.
   PubMed Web of Science ®Google Scholar
• Li X, Feng GS, Zheng CS, et al. (2004). Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level. World J Gastroenterol 10:2878–82.
   PubMed Web of Science ®Google Scholar
• Liang B, Zheng CS, Feng GS, et al. (2010). Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model. Cardiovasc Intervent Radiol 33:806–12.
   PubMed Web of Science ®Google Scholar
• Liapi E, Geschwind JF. (2011). Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? Cardiovasc Intervent Radiol 34:37–49.
   PubMed Web of Science ®Google Scholar
• Liu K, Min XL, Peng J, et al. (2016). The changes of HIF-1α and VEGF expression after TACE in patients with hepatocellular carcinoma. J Clin Med Res 8:297–302.
   PubMedGoogle Scholar
• Liu XB, Cheng Q, Geng W, et al. (2014). Enhancement of cisplatin-based TACE by a hemoglobin-based oxygen carrier in an orthotopic rat HCC model. Artif Cells Nanomed Biotechnol 42:229–36.
   PubMed Web of Science ®Google Scholar
• Lym JS, Nguyen QV, Ahn d. W, et al. (2016). Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy. Acta Biomater 41:253–63.
   PubMed Web of Science ®Google Scholar
• Narayanaswamy R, Torchilin VP. (2019). Hydrogels and their applications in targeted drug delivery. Molecules 24:603.
   PubMed Web of Science ®Google Scholar
• Nouso K, Miyahara K, Uchida D, the Liver Cancer Study Group of Japan, et al. (2013). Liver Cancer Study Group of J. Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan. Br J Cancer 109:1904–7.
   PubMed Web of Science ®Google Scholar
• Otto G, Schuchmann M, Hoppe-Lotichius M, et al. (2013). How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? J Hepatol 59:279–84.
   PubMed Web of Science ®Google Scholar
• Peppas NA, Bures P, Leobandung W, Ichikawa H. (2000). Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 50:27–46.
   PubMed Web of Science ®Google Scholar
• Pietanza MC, Litvak AM, Varghese AM, et al. (2016). A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer. Lung Cancer 99:23–30.
   PubMed Web of Science ®Google Scholar
• Poursaid A, Price R, Tiede A, et al. (2015). In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization. Biomaterials 57:142–52.
   PubMed Web of Science ®Google Scholar
• Qi X, Ng KT, Shao Y, et al. (2016). The clinical significance and potential therapeutic role of GPx3 in tumor recurrence after liver transplantation. Theranostics 6:1934–46.
   PubMed Web of Science ®Google Scholar
• Ranieri G, Ammendola M, Marech I, et al. (2015). Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients. WJG 21:6018–25.
   PubMed Web of Science ®Google Scholar
• Raoul JL, Forner A, Bolondi L, et al. (2019). Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev 72:28–36.
   PubMed Web of Science ®Google Scholar
• Sieghart W, Hucke F, Peck-Radosavljevic M. (2015). Transarterial chemoembolization: modalities, indication, and patient selection. J Hepatol 62:1187–95.
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Ward EM, Jemal A. (2016). Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev 25:16–27.
   PubMed Web of Science ®Google Scholar
• Vauzour D, Vafeiadou K, Rice-Evans C, et al. (2007). Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103:1355–67.
   PubMed Web of Science ®Google Scholar
• Xiong XX, Qiu XY, Hu DX, Chen XQ. (2017). Advances in hypoxia-mediated mechanisms in hepatocellular carcinoma. Mol Pharmacol 92:246–55.
   PubMed Web of Science ®Google Scholar
• Xu K, Cantu DA, Fu Y, et al. (2013). Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds. Acta Biomater 9:8802–14.
   PubMed Web of Science ®Google Scholar
• Xu K, Fu Y, Chung W, et al. (2012). Thiol-ene-based biological/synthetic hybrid biomatrix for 3-D living cell culture. Acta Biomater 8:2504–16.
   PubMed Web of Science ®Google Scholar